Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

Although fewer companies are expected to file for Chapter 11 protections in 2025 relative to last year, significant headwinds ...

Insurers plan to keep sacrificing MA growth for profitability next year, after second quarter results for Humana and CVS ...

The digital musculoskeletal care company hit the public markets in May, one of just a few digital health firms to complete an ...